Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Market Cap	5.19B
Revenue (ttm)	668.70M
Net Income (ttm)	272.95M
Shares Out	80.72M
EPS (ttm)	3.37
PE Ratio	19.08
Forward PE	16.03
Dividend	1.37 (2.14%)
Ex-Dividend Date	Jul 9, 2025

Volume	786,948
Average Volume	995,405
Open	63.40
Previous Close	63.13
Day's Range	63.07 - 64.45
52-Week Range	55.01 - 88.96
Beta	0.36
RSI	59.57
Earnings Date	Apr 23, 2026

About Hangzhou AGS MedTech

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; and EMR products comprising polypectomy snares and disposable sclerotherapy needles. It also provides ESD products, which include electrosurgical generat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 856
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688581

Financial Performance

In 2024, Hangzhou AGS MedTech's revenue was 636.63 million, an increase of 25.14% compared to the previous year's 508.75 million. Earnings were 293.39 million, an increase of 35.06%.